Built to stop resistance before it starts
The only platform that forecasts treatment-emergent resistance risk, giving clinicians confidence to choose therapies that won't fail their most vulnerable patients.
From Reactive to Predictive
No Forecasting Tests
tests on the market can forecast future development of antimicrobial resistance
Resistance Forecasting
Maps whole-genome mutational signatures to forecast resistance risk. Powered by biologically explainable AI trained on massive longitudinal datasets.
Forecast Treatment-Emergent Resistance
Future-proof treatment decisions by understanding resistance-evolution risk
Detect Existing Resistance Patterns
Comprehensive mutational signature analysis across the full genome allows genomics-based susceptibility testing even for complex pathogens and mechanisms
Clinical Validation Progress
Completed
Years of Foundational Research
Developed novel mutational signature biomarkers and AI models
Completed
Proof of Concept Validation
Published in Nature Communications demonstrating resistance forecasting
In Progress
Prospective Clinical Studies
Active validation with leading healthcare institutions
Late 2026
Product Launch
Deployment with pilot health system partners
Partner With Us
We're working with clinical microbiology labs, infectious disease pharmacists, and antimicrobial stewardship programs to bring forecasting to the front lines of patient care.
Start a Conversation